Filter posts

Discrimination Against Vulnerable Patients Is Nothing New

Transformative therapies are advancing like never before, and a new class of medicines are changing …

Harvard Law Advocates for Patient Access to Hepatitis C Cure

There is hope for the 3.5 million people living with Hepatitis C virus (HCV) in …

Points to Consider about the Center for American Progress Prescription Drug Discussion

This afternoon, the Center for American Progress (CAP) Action Fund hosted an obviously one-sided discussion …

Facing growing pressure, N.Y. insurers agree to lift restrictions on hepatitis c therapies

Last week, we wrote about the mounting evidence of insurer discrimination and coverage denials for …

Evidence Mounts of Insurer Discrimination against HIV, HCV Patients

We’ve written before about the problem of discriminatory formulary design in health insurance plans, particularly …

Sara Radcliffe: Legislature Shouldn't Put Hurdles in Way of Cancer Treatments

Check out California Life Sciences Association (CLSA) president and chief executive officer Sara Radcliffe’s op-ed …

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. …

AP: Groups Claim Insurance Discrimination

In this August 18 article, Ricardo Alonso-Zaldivar highlights assertions by patient groups that new insurance …